- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05148611
Application Registration Study of ILE in Patients With Acute Poisoning (ILE)
December 2, 2021 updated by: Peking Union Medical College Hospital
In this study, the investigators aimed to study the effect of ILE in the treatment of acute fat-soluble substance poisoning,to further clarify the relevant mechanism of ILE in the treatment of fat-soluble drug poisoning,to standardize the relevant procedures of ILE detoxification treatment and further explore the adverse reactions and coping strategies of ILE treatment.
Study Overview
Status
Not yet recruiting
Conditions
Detailed Description
Fat-soluble drugs refer to drugs that are insoluble in water but soluble in fats and organic solvents such as carbon tetrachloride, glycerol, oils and other organic solvents.
They can fuse with the phospholipid bilayer of cell membranes, are easily absorbed, and are easier to pass compared to water-soluble drugs.
It is metabolized by the liver, and the metabolites are excreted by the kidneys, so it has a high clinical use rate.
However, in recent years, due to the improper use of fat-soluble drugs by patients, fat-soluble benzodiazepines sedative and hypnotic drugs, fat-soluble calcium channel blockers and β-blocker drugs, fat-soluble tricyclic drugs have often occurred.
Poisoning such as antidepressants poses a serious threat to the lives of patients.In addition, organophosphorus pesticides (fat-soluble) have a high usage rate in China.
Severe organophosphorus poisoning can cause multiple organ damages, and delays in treatment can cause disability or even death.
Clinical treatment is mainly based on routine gastric lavage and oxygen inhalation.
Treatment is the mainstay, combined with medical drugs, hemodialysis, hemoperfusion, etc., and has achieved certain curative effects, but the mortality rate is still high, so it is of great significance to explore safer and more effective treatment methods.Intravenous lipid emulsion (ILE) was originally used to treat overdose of local anesthetics such as bupivacaine, and later also used to treat a variety of other lipophilic drug poisonings.
The research on the treatment of ILE is still in the preliminary stage and relatively limited.
A systematic review of fat emulsions for the treatment of acute poisoning found that the overall quality of the studies supporting this treatment is low or very low, but the included case reports indicate that fat emulsions are effective against verapamil, beta blockers, and certain Tricyclic antidepressants, bupivacaine, chlorpromazine, and certain antiarrhythmic drugs (eg, flecainide) poisoned patients have certain benefits.
ILE may help treat patients who are hemodynamically unstable due to poisoning by these drugs.In view of the fact that the research on the treatment of ILE still needs to be further improved and related adverse reactions need to be further explored related countermeasures, the investigators plan to launch a registration research program related to the application of fat emulsion.
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: yi li, Medical PhD
- Phone Number: 15098750165
- Email: qmbb719@163.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
According to the indications of ILE in the treatment of poisoning in clinical toxicology, the research objects are divided into the following categories:
- Calcium channel blocker poisoning
- Beta blocker drug poisoning
- Tricyclic antidepressant poisoning
- Organophosphorus (fat-soluble) pesticide poisoning, such as: chlorpyrifos, profenofos, diazinon, fenthion, phosphaphos, quinalphos, butylpyrimidin, thiazophos, omethoate, dimethoate Methionine, triazophos, thiomethionine, ethion, sulfoxiphos, imiphos, fosfoxcarb, pyrifoxaphos, hydrocarbophos, phorate, methyl parathion, parasulfur Phosphorus, dichlorvos, pyridoxine, etc.
- Local anesthetic poisoning
- Poisoning by other fat-soluble substances
Description
Inclusion Criteria:
- Diagnosed as acute fat-soluble drug and organophosphorus (fat-soluble) pesticide poisoning;
- Conventional treatment is ineffective, especially for patients with circulatory failure, such as ventricular arrhythmia, shock, cardiac arrest, etc., who need intravenous fat emulsion treatment;
- Those who are not allergic to fat milk;
- Sign informed consent.
Exclusion Criteria:
- Mergers with insufficiency of important organs;
- Patients with malignant tumors;
- Severe mental disorder affects the treatment;
- Those with incomplete clinical data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
mortality rate
Time Frame: 24 hours
|
Patient mortality within 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Circulatory system
Time Frame: 24 hours
|
Circulation stabilization time: including blood pressure stabilization time, disappearance time of malignant arrhythmia, etc.
|
24 hours
|
mortality rate
Time Frame: 1 week and 28 days
|
1 week and 28 days patient mortality
|
1 week and 28 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 30, 2021
Primary Completion (Anticipated)
December 30, 2021
Study Completion (Anticipated)
October 1, 2025
Study Registration Dates
First Submitted
November 1, 2021
First Submitted That Met QC Criteria
December 2, 2021
First Posted (Actual)
December 8, 2021
Study Record Updates
Last Update Posted (Actual)
December 8, 2021
Last Update Submitted That Met QC Criteria
December 2, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ZS-3185D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Poisoning
-
Alexandria UniversityCompletedAcute PoisoningEgypt
-
Sohag UniversityNot yet recruitingAcute Poisoning
-
Giriraj HospitalCompletedStudy to Know the Efficacy of Higher Doses of Pralidoxime in Patients of Organophpsphorus Poisoning.Acute Organophosphorus Pesticide PoisoningIndia
-
Sohag UniversityNot yet recruiting
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
National Institute of Environmental Health Sciences...Completed
-
Amani Hassan Abdel-WahabNot yet recruitingOrganophosphorus Poisoning
-
Rigshospitalet, DenmarkCompletedCarbon Monoxide Poisoning From Fire AccidentsDenmark
-
Sir Salimullah Medical College Mitford HospitalRecruitingOrganophosphorus PoisoningBangladesh
-
Ankara City Hospital BilkentRecruitingCarbon Monoxide PoisoningTurkey